Accedi
Accedi
Oppure accedi con
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Registrati
Oppure accedi con
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

TANGO THERAPEUTICS, INC.

(TNGX)
  Rapporto
Tempo differito Nasdaq  -  22:00 30/11/2022
7.510 USD   +4.02%
11/11Tango Therapeutics, Inc.: prospettiva positiva di Wedbush
MM
10/11La perdita del terzo trimestre di Tango Therapeutics si allarga, ma le entrate aumentano
MT
10/11Tango Therapeutics, Inc. riporta i risultati degli utili per il terzo trimestre e i nove mesi conclusi il 30 settembre 2022
CI
RiassuntoQuotazioniGraficiNotizieRatingCalendarioSocietąFinanzaConsensusRevisioniDerivatiFondi 
RiassuntoTutte le notizieRaccomandazione analistiAltre lingueComunicati stampaPubblicazioni ufficialiNotizie del settore
Notizie in altre lingue su TANGO THERAPEUTICS, INC.
10/11Tango Therapeutics' Q3 Loss Widens, Revenue Higher
10/11Tango Therapeutics: Corporate Presentation
10/11TANGO THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition a..
10/11Tango Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months..
10/11Tango Therapeutics, Inc. Appoints Aaron Weitzman as Chief Medical Officer
10/11Earnings Flash (TNGX) TANGO THERAPEUTICS Posts Q3 Revenue $6.9M
10/11Tango Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business H..
07/11Tango Therapeutics to Participate in Upcoming Investor Conferences
19/10Tango Therapeutics Announces Presentation of Preclinical Data on PRMT5 Inhibitors TNG90..
14/10Tango Therapeutics Rises After Boxer Capital Discloses Share Purchases
05/10Tango Therapeutics: Corporate Presentation
05/10Tango Therapeutics Announces Presentation of Preclinical Data on TNG260 and Discovery P..
05/10Tango Therapeutics Announces Presentation of Preclinical Data on TNG260 and Discovery P..
19/09Tango Therapeutics, Inc.(NasdaqGM:TNGX) added to S&P G..
06/09Tango Therapeutics to Participate in the H.C. Wainwright 24th Annual Global Investment ..
02/09Tango Therapeutics Files $400 Million Mixed Shelf
10/08TANGO THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition a..
10/08Tango Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months..
10/08Tango Therapeutics: Corporate Presentation
10/08Tango Therapeutics: Reports Second Quarter 2022 Financial Results and Provides Business H..
10/08Earnings Flash (TNGX) TANGO THERAPEUTICS Posts Q2 Revenue $5.8M
10/08Tango Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business ..
02/08Tango Therapeutics to Participate in the 13th Annual Wedbush PacGrow Healthcare Confere..
27/06Tango Therapeutics Added to Russell 2000, Russell 3000, Microcap Indexes; Shares Up Pre..
27/06Tango Therapeutics Added to Russell 2000®, 3000® and Microcap® Indexes
24/06Tango Therapeutics, Inc.(NasdaqGM:TNGX) added to Russe..
24/06Tango Therapeutics, Inc.(NasdaqGM:TNGX) added to Russe..
24/06Tango Therapeutics, Inc.(NasdaqGM:TNGX) added to Russe..
24/06Tango Therapeutics, Inc.(NasdaqGM:TNGX) added to Russe..
24/06Tango Therapeutics, Inc.(NasdaqGM:TNGX) added to Russe..
24/06Tango Therapeutics, Inc.(NasdaqGM:TNGX) added to Russe..
24/06Tango Therapeutics, Inc.(NasdaqGM:TNGX) added to Russe..
24/06Tango Therapeutics, Inc.(NasdaqGM:TNGX) added to Russe..
24/06Tango Therapeutics, Inc.(NasdaqGM:TNGX) added to Russe..
24/06Tango Therapeutics, Inc.(NasdaqGM:TNGX) added to Russe..
24/06Tango Therapeutics, Inc.(NasdaqGM:TNGX) added to Russe..
24/06Tango Therapeutics, Inc.(NasdaqGM:TNGX) added to Russe..
24/06Tango Therapeutics, Inc.(NasdaqGM:TNGX) added to Russe..
23/06Tango Therapeutics: Corporate Presentation
10/06Tango Therapeutics, Inc.: Submission of Matters to a Vote of Security Holders (form 8-K)
08/06Tango Therapeutics to Participate in the Goldman Sachs 43rd Annual Global Healthcare Co..
20/05Tango Therapeutics: Corporate Presentation
11/05Sector Update: Health Care Stocks Edging Lower Ahead of Wednesday Close
11/05Sector Update: Health Care
11/05Tango Therapeutics Posts Q1 Loss, Revenue Falls
11/05TANGO THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition a..
11/05Tango Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31,..
11/05Tango Therapeutics Reports First Quarter 2022 Financial Results and Provides Business H..
09/05Tango Therapeutics to Participate in the Guggenheim Synthetic Lethality Day 2022
07/04Tango Therapeutics: Corporate Presentation
28/03Tango Therapeutics: Corporate Presentation
28/03Tango Therapeutics Q4 Net Loss Widens as Revenue Falls
28/03TANGO THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition a..
28/03Tango Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, ..
28/03Tango Therapeutics: Reports Fourth Quarter and Full Year 2021 Financial Results and Provi..
28/03Tango Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December..
28/03Earnings Flash (TNGX) TANGO THERAPEUTICS Posts Q4 Loss $-0.25
28/03Earnings Flash (TNGX) TANGO THERAPEUTICS Reports Q4 Revenue $5.7M
28/03Tango Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Prov..
08/03Tango Therapeutics Announces Presentation of Preclinical Data on TNG908, USP1 Inhibitor..
03/03Tango Therapeutics Announces Presentation of TNG908 Preclinical Combination Data at 202..
28/02Tango Therapeutics to Participate in Upcoming Investor Conferences
09/02Tango Therapeutics: Corporate Presentation
02/02Tango Therapeutics to Participate in Upcoming Investor Conferences
24/01Tango Therapeutics Gets FDA Go-Ahead to Start First-in-Human Cancer Drug Trial
24/01Tango Therapeutics Gets FDA OK for Cancer-Drug Trial
24/01Tango Therapeutics: Corporate Presentation
24/01Tango Therapeutics Announces Clearance of TNG908 IND by FDA and Recent Pipeline Progres..
24/01Tango Therapeutics Announces Clearance of TNG908 IND by FDA and Recent Pipeline Progres..
24/01Tango Therapeutics Appoints Dr. Michael Palmieri as Head of CMC
2021Tango Therapeutics to Participate in the Jefferies London Healthcare Conference
2021TANGO THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition a..
2021Tango Therapeutics Corporate Presentation
2021Tango Therapeutics Reports Narrower Q3 Net Loss
2021Tango Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business H..
2021Earnings Flash (TNGX) TANGO THERAPEUTICS Reports Q3 Loss $-0.28
2021Earnings Flash (TNGX) TANGO THERAPEUTICS Posts Q3 Revenue $6.8M
2021Tango Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business H..
2021Tango Therapeutics Corporate Presentation
2021Tango Therapeutics Announces Appointment of Dr. Marc Rudoltz as Chief Medical Officer a..
2021Tango Therapeutics Announces Appointment of Dr. Marc Rudoltz as Chief Medical Officer
2021Tango Therapeutics: Corporate Presentation
2021Tango Therapeutics: Announces Presentation of Preclinical Data on Lead Program and Discov..
2021Tango Therapeutics, Inc.(NasdaqCM:TNGX) added to S&P T..
2021Tango Therapeutics, Inc.: Entry into a Material Definitive Agreement, Completion of Acqui..
2021Bctg Acquisition: Tango Therapeutics Debuts as Publicly Traded Precision Oncology Company..
2021BCTG Acquisition Corp.(NasdaqCM:BCTG) dropped from NASDA..
2021Tango Therapeutics, Inc. completed the acquisition of BCTG Acquisition Corp. from Boxer..
2021Tango Therapeutics, Inc. announced that it has received $186.1 million in funding from ..
2021Bctg Acquisition Corp. Reports Earnings Results for the Half Year Ended June 30, 2021
2021Bctg Acquisition: Management's Discussion and Analysis of Financial Condition and Results..
2021Bctg Acquisition: Management's Discussion and Analysis of Financial Condition and Results..
2021Bctg Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2..
2021Sector Update: Health Care Stocks Giving Back Most of Wednesday Gains
2021Sector Update: Health Care Stocks Narrowly Mixed in Recent Trade
2021Bctg Acquisition Corp.: Entry into a Material Definitive Agreement, Unregistered Sale of ..
2021BCTG Acquisition Corp. Announces Executive Resignations
2021BCTG Acquisition : Tango Therapeutics to Go Public via Merger with BCTG..
2021Tango Therapeutics, Inc. entered into an agreement to acquire BCTG Acquisition Corp. fr..
2021Tango Therapeutics, Inc. announced that it expects to receive $186.1 million in funding..
Prossimo evento su TANGO THERAPEUTICS, INC.